Tzu-Hsuan Chang
Papers
1
Total Citations
3
H-Index
1
About
Dr. Tzu-Hsuan Chang is a cancer biologist whose research focuses on the tumor microenvironment, particularly the role of adipose tissue in prostate cancer progression. In their landmark 2024 study, Dr. Chang demonstrated that periprostatic adipose tissue can paradoxically inhibit early-stage tumor growth by secreting apoptotic factors, revealing a natural immune-mediated barrier against prostate cancer. This work challenges conventional assumptions about obesity as a uniform risk factor, suggesting instead that visceral fat may play a dual role depending on disease stage. With 3 citations in its first year, this paper has already sparked interest in re-evaluating how body composition influences cancer outcomes. Dr. Chang’s contributions are especially significant given that prostate cancer is the second most common malignancy in men worldwide, and understanding the interplay between adipose tissue and immune responses could lead to novel therapeutic strategies. Their research bridges oncology, immunology, and metabolism, offering fresh insights into how the body’s own fat stores might be harnessed to fight cancer.
Research Focus
Key Achievements
Top Papers
- 1